Atazanavir Capsules bulk supplier for pharma manufacturers

Atazanavir Capsules 100 mg, 200 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 100 mg, 200 mg, 300 mg

Reference Brands: Reyataz (USA/EU/UK)

Atazanavir capsules 100 mg, 200 mg and 300 mg, an HIV protease inhibitor given with a booster. For importers, distributors, national HIV programmes, hospitals and donor-funded tender buyers.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Atazanavir Capsules? List it or send an offer →

Product Description:

Atazanavir is an HIV-1 protease inhibitor. It blocks the viral protease that cuts protein chains into working parts, so new virus particles stay immature and cannot infect further cells. This page covers hard capsules of 100 mg, 200 mg and 300 mg. The 300 mg capsule gives the usual adult dose in one unit beside a separate booster, while lower strengths fit weight-based dosing in children. Fixed-dose tablets with ritonavir are also widely used in national programmes.

Atazanavir is used in combination antiretroviral therapy, almost always boosted with low-dose ritonavir or cobicistat; WHO guidance lists boosted atazanavir among second-line protease inhibitor options. Capsules are swallowed whole once daily with food. Absorption needs stomach acid, so proton pump inhibitors are avoided or restricted and H2 blockers and antacids need careful timing. Rifampicin and St John's wort are contraindicated. Raised unconjugated bilirubin, sometimes with jaundice, is common and reflects UGT1A1 inhibition, not liver damage. PR prolongation, kidney stones and gallstones also occur.

Sourcing notes. Atazanavir is prescription-only and often bought through national HIV programmes and donor-funded tenders, where WHO prequalification or stringent authority approval is usually a condition of supply; confirm it for the exact strength and pack. The drug substance is atazanavir sulfate, and the capsules are moisture-sensitive, so bottles with desiccant or protective blisters are standard. Ask for zone IVb stability data, a CoA per batch, the GMP certificate, a CoPP, the bioequivalence study and a CTD or ACTD dossier. State strength, capsules per bottle and label language.

Atazanavir Capsules — third party manufacturing & bulk supply

Atazanavir Capsules 100 mg, 200 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Atazanavir Capsules is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Atazanavir Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Atazanavir Capsules →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Atazanavir is used for the treatment of HIV-1 infection as part of combination antiretroviral therapy. It helps reduce viral load, increase CD4 cell counts, and slow the progression of HIV disease.

Atazanavir is made from the active ingredient atazanavir sulfate, a protease inhibitor that blocks the HIV protease enzyme. By inhibiting this enzyme, it prevents the virus from producing mature and infectious viral particles.

The most commonly known trade name for atazanavir is Reyataz.

Reyataz was originally developed and marketed by Bristol-Myers Squibb. Many other pharmaceutical manufacturers also produce generic atazanavir in different global markets.

The generic name is atazanavir sulfate.

The primary brand name is Reyataz, along with several generic brand formulations depending on the country and manufacturer.

Atazanavir is manufactured by several approved pharmaceutical companies in India, the United States, Europe, and other global regions, depending on whether it is a brand or generic product.